109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
siRNA targeting nuclear receptor interacting protein 1 (NRIP1)
#9002siRNa targeting neuropilin 1 (NRP1)
#9003Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides
#9004Methods and Compositions to Inhibit P2x7 Receptor Expression
#9005Efficient Method of Preparing Dna Inverted Repeat
#9006Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions
#9007Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
#9008Methods of diagnosing pre-eclampsia or eclampsia
#9009Methods for Identifying Genes that Mediate a Response of a Living Cell to an Agent
#9010Dek protein compositions and methods of using the same
#9011Method of Making an Artificial Nuclease for Anti-viral, Anti-bacterial Applications
#9012siRNA targeting protein kinase N-3 (PKN-3)
#9013Methods and compositions for controlling efficacy of RNA silencing
#9014INTRANASAL DELIVERY OF NUCLEIC ACID MOLECULES
#9015Blockade of Calcium Channels
#9016Novel Method of Nucleic Acid Transfer
#9017Inhibition of Infiltration, and Cell Killing Agent
#9018METHOD FOR SUSTAINABLE TRANSGENE TRANSCRIPTION
#9019Amino acid lipids and uses thereof
#9020Treatment of Cancer Using Tlr3 Agonists
#9021Mammalian receptor protein DCRS5; methods of treatment
#9022Methods and compositions for regulating HDAC4 activity
#9023WATER SOLUBLE CROSSLINKED POLYMERS
#9024Tetracycline-Dependent Regulation of Rna Interference
#9025Combined hairpin-antisense compositions and methods for modulating expression
#9026DNA constructs for specific inhibition of gene expression by RNA interference
#9027Use of Sirnas in Organ Storage/Reperfusion Solutions
#9028Engineered Dopamine Neurons and Uses Thereof
#9029Bacteria mediated gene silencing
#9030METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
#9031Nucleic acid functionalized nanoparticles for therapeutic applications
#9032siRNA targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)
#9033Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
#9034MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers
#9035Method of Generating Translationally Active Linear Dna Molecules and Use Thereof in Array Formats
#9036Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer
#9037siRNA targeting vascular endothelial growth factor receptor 1 (VEGFR1)
#9038Alpha-Synuclein Kinase
#9039Cell cycle arrest and apoptosis
#9040Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
#9041NUCLEIC ACID COMPOUNDS FOR INHIBITING APOB GENE EXPRESSION AND USES THEREOF
#9042Methods of inhibiting smooth muscle cell migration and proliferation
#9043Host cell protein knock-out cells for production of therapeutic proteins
#9044TREATMENT OF CHEMOTHERAPY- OR RADIOTHERAPY-RESISTANT TUMORS
#9045Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#9046RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
#9047FC gamma RIIA-specific nucleic acid interference
#9048Tandem siRNAS
#9049siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
#9050siRNA targeting casitas B cell lymphoma-B (CBL-B)
#9051Multiple shRNA Expression Vectors and Methods of Construction
#9052NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
#9053shRNA Materials and Methods of Using Same for Inhibition of DKK-1
#9054Pharmaceutical Composition Containing Meltrin Antagonist
#9055Intranuclear protein transduction through a nucleoside salvage pathway
#9056Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
#9057SiRNA-based cancer treatment
#9058NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB GENE EXPRESSION AND USES THEREOF
#9059Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
#9060Injectable Agent for the Targeted Treatment of Retinal Ganglion Cells
#9061CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH
#9062NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF GENE EXPRESSION AND USES THEREOF
#9063Structures of Active Guide Rna Molecules and Method of Selection
#9064PIT-1 AND VASCULAR CALCIFICATION
#9065Oligoribonucleotide Inhibiting Growth of Tumor Cells and Method Therefor
#9066SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTASIS
#9067Compositions for treating respiratory viral infections and their use
#9068ALK protein tyrosine kinase, cells and methods embodying and using same
#9069Methods for treating cancer targeting transglutaminase
#9070Methods and compositions for modulating vascular integrity
#9071Nucleic Acids Against Viruses, in Particular Hiv
#9072Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
#9073Lipids, lipid complexes and use thereof
#9074Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics
#9075ShRNA molecules and methods of use thereof
#9076E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof
#9077Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
#9078Inhibitors of RTP801 and their use in disease treatment
#9079Modified small interfering RNA molecules and methods of use
#9080RNA interference mediating small RNA molecules
#9081Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
#9082siRNA targeting forkhead box P3 (FOXP3)
#9083Model system for identifying anti-cancer agents
#9084High viscosity macromolecular compositions for treating ocular conditions
#9085Soluble ErbB3 and treatment of cancer
#9086Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling
#9087Methods of controlling bone loss by inhibiting DKK1
#9088Compositions for silencing the expression of VDAC1 and uses thereof
#9089COMPOSITIONS AND METHODS OF SPHINGOSINE KINASE INHIBITORS IN RADIATION THERAPY OF VARIOUS CANCERS
#9090Methods and compositions for identifying anti-HCV agents
#9091Modified Nucleosides for Rna Interference
#9092Chimeric Gapped Oligomeric Compounds
#9093METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#9094Method and medicament for inhibiting the expression of a given gene
#9095ARL-1 specific antibodies
#9096siRNA molecules for the treatment of blood vessels
#9097Preventives/Remedies for Cancer
#9098Organic Compounds
#9099Method for identifying compounds for treatment of pain
#9100Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses Thereof
#9101Method for inhibiting scavenger receptor-A and increasing immune response to antigens
#9102TREATMENT OF CANCER USING TLR3 AGONISTS
#9103Neuron regeneration
#9104RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)
#9105AGENTS THAT REDUCE NEURONAL OVEREXCITATION
#9106Modified siRNA molecules and uses thereof
#9107RNA interference mediated inhibition of sterol regulatory element binding protein 1 (SREBP1) gene expression using short interfering nucleic acid (siNA)
#9108Modified Short Interfering Rna (Modified Sirna)
#9109Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof
#9110Genetic inhibition of double-stranded RNA
#9111Method for Improved Selection of Rnai Transfectants
#9112Regulation of mink in thymocytes and T lymphocytes
#9113THERAPEUTIC AGENT FOR CANCER, INFLAMMATION, AND AUTO-IMMUNE DISEASE CONTAINING INHIBITOR OF ZINC FINGER PROTEIN 91
#9114Inflammation treatment, detection and monitoring via TREM-1
#9115Modified polynucleotides for reducing off-target effects in RNA interference
#9116Multi-targeting short interfering RNAs
#9117Impaired wound healing compositions and treatments
#9118Inhibiting Gene Expression with dsRNA
#9119Nucleotide-Cochleate Compositions And Methods Of Use
#9120Identification of genetic alterations that modulate drug sensitivity in cancer treatments
#9121Methods and compositions for the inhibition of HIV-1 replication
#9122Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
#9123Prohibitin as Target for Cancer Therapy
#9124Method of designing siRNAs for gene silencing
#9125Methods and compositions for reducing viral genome amounts in a target cell
#9126Sirna For Inhibiting Il-6 Expression and Composition Containing Them
#9127Inhibitor Nucleic Acids
#9128Materials and methods for treatment of allergic disease
#9129Method and medicament for inhibiting the expression of a given gene
#9130RNAi modulation of MLL-AF4 and uses thereof
#9131siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
#9132Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering Agent
#9133Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain
#9134Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#9135Methods to increase or decrease bone density
#9136Cell-Based Rna Interference and Related Methods and Compositions
#9137RNA interference and disease resistance in avians
#9138siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR)
#9139siRNA targeting ethanolamine Kinase I1 (EKI1)
#9140Treatment tool for cancer: RNA interference of BCAS2
#9141Compositions and methods for inhibiting expression of Huntingtin gene
#9142Inhibiting Gene Expression with dsRNA
#9143Vectors and Methods Using Same
#9144Oligonucleotide probes useful for detection and analysis of microRNA precursors
#9145Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
#9146Products and Methods Related to Mono-Methyl Branched-Chain Fatty Acids
#9147Aptamer-mediated intracellular delivery of oligonucleotides
#9148Triggered RNAi
#9149RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
#9150Method of inducing an immune response
#9151Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
#9152RNAi Agents Comprising Universal Nucleobases
#9153Methods and compositions for RNA interference
#9154NOVEL C. ELEGANS P21-ACTIVATED KINASE (PAK) GENE AND ASSOCIATED LOSS-OF-FUNCTION PHENOTYPES THAT FACILITATE SCREENING FOR SMALL MOLECULE MODULATORS OF PAK ACTIVITY IN THE NEMATODE, CAENORHABDITIS ELEGANS
#9155Hepcidin, hepcidin antagonists and methods of use
#9156Preventive and/or Treating Agent for Cancer
#9157Method of predicting and reducing risk of metastasis of breast cancer to lung
#9158Methods and compositions for treatment of myotonia
#9159Nanoparticles Comprising Rna Ligands
#9160siRNA targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)
#9161Methods and Compositions for Treating 5Alpha-Reductase Type 1 and Type 2 Dependent Conditions
#9162RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
#9163Self-Processing Rna Expression Cassette
#9164Nucleic Acid Complex
#9165Methods and Compositions Relating to Gene Silencing
#9166Invertebrate microRNAs
#9167In vivo production of small interfering RNAs that mediate gene silencing
#9168Methods for the Delivery of Oligomeric Compounds
#9169NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS
#9170Methods For Suppressing Tumor Proliferation
#9171Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
#9172RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION
#9173Compositions and methods for inhibiting viral replication
#9174Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals
#9175Antisense modulation of p38 mitogen activated protein kinase expression
#9176Highly Potent Hsirna Mixtures and Method for Gene Splicing
#9177siRNA targeting human hairless protein (HR)
#9178siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)
#9179Compositions and Methods for siRNA Inhibition of Angiogenesis
#9180RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#9181Synthetic siRNA compounds and methods for the downregulation of gene expression
#9182BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL HIV REGULATORY GENES AND USES THEREOF
#9183Methods For Gene Targeting
#9184Compositions and methods for repressing the Ink4a and Arf senescence pathways
#9185Method and medicament for inhibiting the expression of a given gene
#9186UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING
#9187OLIGORIBONUCLEOTIDES FOR THE TREATMENT OF DEGENERATIVE SKIN CONDITIONS BY RNA INTERFERENCE
#9188Methods and compositions involving MicroRNA
#9189Lung cancer-related nucleic acids
#9190Nucleic acids encoding proteins for modulating Na,K-ATPase
#9191siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#9192Allele-specific silencing of disease genes
#9193Methods and compositions involving miRNA and miRNA inhibitor molecules
#9194Treating hepatitis C virus infection
#9195Method and medicament for inhibiting the expression of a given gene
#9196Method and medicament for inhibiting the expression of a given gene
#9197RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
#9198Methods and compositions involving miRNA and miRNA inhibitor molecules
#9199Methods and Compositions Involving microRNA
#9200Expression system
#9201Cancer Treatment
#9202Cd44 Variants As Therapeutic Targets
#9203Modulation of FR-alpha expression
#9204Cancer Therapy Via the Inhibition of Skp-2 Expression
#9205Method and medicament for inhibiting the expression of a given gene
#9206Method to Inhibit the Propagation of an Undesired Cell Population
#9207siRNA targeting serine/threonine protein kinase AKT
#9208Alpha-synuclein kinase
#9209Tat-based immunomodulatory compositions and methods of their discovery and use
#9210Oligonucleotides for RNA interference and biological applications thereof
#9211Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
#9212Treatment of neurological disorders by dsRNA administration
#9213Methods of use of bcl-6-derived nucleotides to induce apoptosis
#9214System and Methods For Short Rna Expression
#9215Method of delivering RNA interference and uses thereof
#9216Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
#9217COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
#9218Positionally modified siRNA constructs
#9219Methods of treating cutaneous ulcers and grafts using IL-23
#9220Methods And Compounds For Altering The Load Of Hepatitis Virus
#9221Compositions and Methods for the Treatment and Prevention of Neoplastic Disorders
#9222siRNA targeting synuclein, alpha (SNCA-1)
#9223siRNA targeting myeloid cell leukemia sequence 1
#9224Compositions and Methods That Enhance Rna Interference
#9225CASPASE-8 INTERACTING PROTEINS
#9226Methods of treating pre-eclampsia and eclampsia
#9227Method for producing transgenic rats
#9228siRNA targeting kinase insert domain receptor (KDR)
#9229SHC proteins as therapeutic targets in proliferative diseases
#9230RNA sequence-specific mediators of RNA interference
#9231Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
#9232Novel Regulatory Protein
#9233Ribonucleic acid interference molecules
#9234RNA interference agents for therapeutic use
#9235SIMULTANEOUS SILENCING AND RESTORATION OF GENE FUNCTION
#9236MicroRNA1 therapies
#9237Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals
#9238Bead based receptor biology
#9239Compositions and methods for angiogenesis-related molecules and treatments
#9240Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
#9241Combined use of PRAME inhibitors and HDAC inhibitors
#9242MAIZE MICRORNA SEQUENCES
#9243Functional and hyperfunctional siRNA directed against Bcl-2
#9244RNAi modulation of Aha and therapeutic uses thereof
#9245Compositions and methods for inhibiting expression of the PCSK9 gene
#9246siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
#9247siRNA targeting proto-oncogene MET
#9248siRNA targeting myeloid differentiation primary response gene (88) (MYD88)
#9249siRNA targeting superoxide dismutase 1 (SOD1)
#9250siRNA targeting fructose-1,6-bisphosphatase 1 (FBP1)
#9251siRNA targeting amyloid beta (A4) precursor protein (APP)
#9252siRNA targeting glucagon receptor (GCGR)
#9253siRNA targeting beta secretase (BACE)
#9254siRNA targeting apolipoprotein B (APOB)
#9255siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)
#9256Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same
#9257RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING
#9258CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
#9259Functional and hyperfunctional siRNA directed against Bcl-2
#9260Functional and hyperfunctional siRNA directed against Bcl-2
#9261Lipophilic conjugated iRNA agents
#9262Compositions and methods for inhibiting expression of IKK-B gene
#9263siRNA targeting kinases
#9264siRNA targeting TNFalpha
#9265Functional and hyperfunctional siRNA directed against Bcl-2
#9266siRNA targeting deubiqutination enzymes
#9267Small Interfering Rna and Pharmaceutical Composition for Treatment of Hepatitis B Comprising the Same
#9268CRAC modulators and use of same for drug discovery
#9269Animal models for demyelination disorders
#9270Functional and hyperfunctional siRNA directed against Bcl-2
#9271Functional and hyperfunctional siRNA directed against Bcl-2
#9272Functional and hyperfunctional siRNA directed against Bcl-2
#9273Functional and hyperfunctional siRNA directed against Bcl-2
#9274siRNA targeting complement component 3 (C3)
#9275EML4-ALK fusion gene
#9276Antagonist of TEB4 and Methods of Use
#9277Polypeptide fragment of constitutive coactivator of PPARgamma
#9278Compositions and methods for the modulation of detrusor activity
#9279siRNA targeting secreted frizzled-related protein 1 (sFRP1)
#9280SiRNA targeting intercellular adhesion molecule 1 (ICAM1)
#9281MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS
#9282siRNA targeting transient receptor potential cation channel, subfamily V, member 1 (TRPV1)
#9283siRNA targeting phosphoinositide-3-kinase, class 2, beta polypeptide (PIK3C2B)
#9284Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
#9285Cancer Treatment
#9286VEHICLE FOR THE TRANSPORT OF A CHOSEN MOLECULE TO A CELL
#9287siRNA targeting carbonic anhydrase 4(CA4)
#9288Methods and compositions for inhibiting the function of polynucleotide sequences
#9289Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi
#9290Genetic inhibition by double-stranded RNA
#9291siRNA targeting nuclear receptors
#9292Novel method of protecting islet cells from apoptosis during the donor harvesting process
#9293DICER SUBSTRATE RNA PEPTIDE CONJUGATES AND METHODS FOR RNA THERAPEUTICS
#9294siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)
#9295siRNA targeting ubiquitin ligases
#9296Cytoplasmic Localization Dna and Rna
#9297Pharmaceutical Agents for Preventing Metastasis of Cancer
#9298MEDICAMENT TO TREAT A FIBROTIC DISEASE
#9299Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes
#9300Conserved HBV and HCV sequences useful for gene silencing